In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

Faculty Disclosures

Moderator:

Richard Reitherman PHD MD—Nothing to disclose

Dr. Reitherman is medical director of breast imaging at Memorial Care Breast Center at Orange Coast, Fountain Valley, CA, and a clinical assistant professor, Radiology, Harbor UCLA Medical Center. He received his doctorate in neuroscience from the University of California, San Diego and completed a post-doctoral fellowship at the Salk Institute in La Jolla, CA. He earned his medical degree from the University of Southern California (USC) School of Medicine, and then completed his internship in internal medicine as well as his residency in diagnostic radiology at L.A. County USC Medical Center. 
Dr. Reitherman is well-known for his clinical role in the early adaptation, promotion, and refinement of breast MRI with more than 20 years of experience in breast imaging and intervention. He has published many peer-reviewed articles and abstracts, written more than 20 editorials, and presented at more than 40 conferences nationally and internationally. He serves on the Board of Directors of the American Society of Breast Disease (ASBD), is chair of the ASBD Breast Specialty Training Committee, and has served as a member of the ASBD Screening Guidelines Committee and Breast MRI Consensus Committee. He is currently a member of the NAPBC Education Committee. His special clinical and research interests include improving screening for high-risk women less than 40 years of age, multimodality imaging correlation with large section histopathology, and implementation of standardized workflow algorithms for breast cancer screening based on individual risk profiling. 

Panelists:

Emily Monteleone, MBA—Nothing to disclose

Ms. Monteleone is a program manager at Cleveland Clinic’s Taussig Cancer Center, where she oversees the cancer programming efforts supporting the multidisciplinary cancer programs for breast and colorectal cancers. She holds a bachelor of science in biology from John Carroll University and an MBA with a concentration in Health Care Administration from Cleveland State University.

Ms. Monteleone also enjoys giving back to her community in many ways, including sitting on the board for GiGi’s Playhouse Cleveland, Down Syndrome Achievement Center.

Shilpa Padia, MD—Nothing to disclose

Dr. Padia is a fellowship-trained breast surgeon practicing at Mount Carmel Health System, Columbus, OH. She has served as the co-medical director of Breast Cancer Services since 2016. Dr. Padia joined Mount Carmel after completing her fellowship in surgical breast oncology at The Cleveland Clinic.  She is an Associate Fellow of the American College of Surgeons, a member of the American Society of Breast Surgeons and Society of Surgical Oncology, and is a member of Alpha Omega Alpha medical honor society. Dr. Padia is a clinical assistant professor of surgery at the Northeast Ohio Medical University. In February 2019, she enrolled in an integrative medicine fellowship through the University of Arizona with anticipated graduation in February 2021. Dr. Padia’s goal is to incorporate integrative medicine throughout her practice, emphasizing prevention, cancer care, and survivorship. 

Sarah Nelson, MS, RDN, CD, CSO—Nothing to disclose

Ms. Nelson is not only a registered dietitian, but also a certified specialist in oncology, dedicating her nutrition practice to cancer care. She received her undergraduate degree from the University of Wisconsin-Green Bay (UWGB) and completed her combined masters/dietetic internship at Benedictine University, Lisle, IL. Ms. Nelson created the outpatient oncology dietitian role at Hospital Sisters Health Systems St. Vincent Hospital Cancer Centers six years ago. By implementing protocols and best practice through the electronic medical record as well as within clinic flow, she has guided patients and their family support during difficult cancer treatment. Ms. Nelson developed and continues to expand the outpatient oncology nutrition program for surgical, medical and radiation oncology throughout four physical locations. By serving on a variety of committees within the cancer center, she represents the importance of nutrition among multiple providers and programming efforts. Ms. Nelson precepts dietetic interns from UWGB and has developed an oncology nutrition “crash course” for interns who are unable to add an oncology rotation. 
 

Program Committee Disclosures 

Katharine Yao, MD, FACS—Nothing to disclose
NorthShore University HealthSystem

Ian Greenwalt, MD—Nothing to disclose
Medstar Georgetown University Hospital

Misty Harrison-Gwin, ASN, RN, CRN—Nothing to disclose
Reid Health

Rachael Lancaster, MD—Nothing to disclose
The University of Alabama at Birmingham (UAB)

Mehra Golshan, MD, FACS—Nothing to disclose
Dana Farber/Brigham and Women’s Cancer Center   

Judy Kneece, RN, OCN—Salary from Educare, Inc.     
EduCare, Inc.

Scott Kurtzman, MD, FACS—Nothing to disclose        
Waterbury Hospital

William Laffey, MBA—Nothing to disclose     
The Laffey Partnership

Denise Mammolito, MD, FACS—Nothing to disclose
University of Illinois College of Medicine at Peoria

Melissa Nye, RN, BA, CN-BN—Nothing to disclose
Breast Advocates International

Richard Reitherman, MD—Nothing to disclose
National Consortium of Breast Centers (NCBC)

Colette Salm-Schmid, MD, FACS—Nothing to disclose
Prevea/HSHS St. Vincent’s Regional Cancer Program

Asa Carter, MBA, CTR—Nothing to disclose
American College of Surgeons

Chantel Ellis—Nothing to disclose
American College of Surgeons

Andrea Scrementi—Nothing to disclose
American College of Surgeons